Biotechnology News

June 12, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced the publication of new pre-clinical results in the journal Blood (doi: 10.1182/blood-2012-04-423715) that describe...

June 12, 2012

OWINGS MILLS, Md.--(BUSINESS WIRE)--GoIndustry DoveBid, the global leaders in surplus asset management, was selected by Bionovo, Inc. to provide a disposition channel for their surplus assets via the BioPharma Exchange Program.

June 12, 2012

TORONTO--(BUSINESS WIRE)--United States electrophysiology (EP) mapping and ablation device market will grow strongly through 2016.

June 12, 2012

LAFAYETTE, Colo.--(BUSINESS WIRE)--Aegis Analytical Teams up with Sequence. Partner helps Life Sciences Manufacturers Validate Discoverant Software.

June 12, 2012

BOSTON--(BUSINESS WIRE)--This week the Games for Health Project kicks off its eighth annual Games for Health Conference, the nation’s largest conference dedicated to videogames, health, and health care, from June 12-14 in Boston. The conference,...

June 12, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that its lead candidate, galeterone (TOK-001), has received Fast Track...

June 12, 2012

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Jane Wasman, Chief, Strategic Development and General Counsel, will present at the Wells Fargo 2012 Healthcare Conference on Tuesday, June 19, 2012 at...

June 12, 2012

DUBLIN--(BUSINESS WIRE)--Clinical Research, CRO, Peter Gray, ICON plc, ICON Clinical Research

June 12, 2012

TARRYTOWN, N.Y.--(BUSINESS WIRE)--PsychoGenics Inc. today reported positive results from a clinical study of eltoprazine in levodopa induced dyskinesia (LID) in Parkinson's disease (PD) patients.

June 12, 2012

MILAN--(BUSINESS WIRE)--First patient enrolment in the DREAM clinical trial that will evaluate sensitivity and positive predictive value of Sleep Apnea Monitoring (SAM) in pacemaker patients compared to polysomnography

June 12, 2012

RESTON, Va.--(BUSINESS WIRE)--Aptiv Solutions, a biopharmaceutical and medical device development services company, and leader in adaptive clinical trial design, simulation and execution, announced today that the company’s medical device services...

June 12, 2012

GATWICK, England--(BUSINESS WIRE)--Systagenix wound management acquires point-of-care diagnostics company O2 Insights Inc, to build its position as a global leader in wound diagnostics following the launch of WOUNDCHEK™ Protease Status

June 12, 2012

LUND, Sweden & LONDON--(BUSINESS WIRE)--BioInvent and Cancer Research Technology enter Oncology collaboration

June 12, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sanofi and Genzyme announced that it has submitted a supplemental Biologics License Application to the FDA and a marketing authorization application to the EMA seeking approval of LEMTRADA™ for MS.

June 12, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Avedro launches riboflavins specifically formulated for faster diffusion, trans-epithelial use, and for use directly on the stromal bed within a standard Lasik procedure.

June 11, 2012

VANCOUVER--(BUSINESS WIRE)--STEMCELL Technologies Inc. to Launch TeSR-E8 - a Novel Medium for Human Embryonic and Induced Pluripotent Stem Cells - and New STEMdiff Kits for Differentiation of these cell types

June 11, 2012

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) today reported results for the fiscal third quarter ended April 30, 2012. Among the quarter’s highlights were the following: Revenue increases compared to year-earlier same period....

June 11, 2012

NEW YORK--(BUSINESS WIRE)--Hessen, Germany will be featured as a leading business location for the life science industry at the BIO International Convention, June 18-21, 2012 in Boston, MA

June 11, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc. announces that the clinical utility of the Company’s lead diagnostic product Quantose™ IR will be featured in five poster presentations at the 72nd Annual Scientific Sessions of the...

June 11, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Data Comparing Navidea’s AZD4694 to Gold-Standard 11C-PIB in Beta Amyloid Imaging Presented at Society of Nuclear Medicine Meeting

June 11, 2012

WASHINGTON--(BUSINESS WIRE)--The 2012 BIO International Convention looks to give a global perspective on regulatory and acceptance issues within the food and agriculture and industrial and environmental sectors of the industry through the...

June 11, 2012

BOSTON--(BUSINESS WIRE)--Lyonbiopôle, worldwide health & biotech competitiveness cluster, focused on infectious diseases and cancers, invites you to join them on Monday 18th June at the W Boston Hotel in Boston (MA) to explore net working...

June 11, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--3M and the WOCN Society announce that the Adult Critical Care Skin Care Team from Strong Memorial Hospital of Rochester, N.Y., is the inaugural recipient of the 3M Award for Excellence in Skin Safety.

June 11, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science, Inc. (CBIS), a pioneering U.S. biotech company developing pharmaceutical cannabis-based products, is pleased to announce the Company’s new acquisition of the “Trimcare Brand” including...

June 11, 2012

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials today announced that Dr. Bill Petty, Chairman and CEO, will...

June 11, 2012

MENLO PARK, Calif.--(BUSINESS WIRE)--Mountain View Pharmaceuticals has received a European Patent covering “Polyethylene Glycol Conjugates of Interferon-beta-1b with Enhanced in vitro Biological Potency.”

June 11, 2012

CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Linguamatics is pleased to announce that they are providing access to clinical trials data with their market-leading I2E text mining platform. This new service, adding data from the ClinicalTrials...

June 11, 2012

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTCBB:TBIO) announced that the US Patent and Trademark Office has issued patent number US 8,137,919 entitled “Method of Determining the Sensitivity of Cancer Cells to EGFR Inhibitors including...

June 11, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the Company’s five-year strategic aspirations – Building Blocks of Growth – at its Investor Day at the NASDAQ Market Site. Cubist’s President and Chief...

June 11, 2012

CHALFONT ST. GILES, UK--(BUSINESS WIRE)--GE Healthcare today announced a collaboration with Australian Commonwealth Scientific and Industrial Research Organisation (CSIRO) involving its investigational PET imaging agent [18F flutemetamol]. Under...

June 11, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Syapse announced today the commercial launch of Discovery, its cloud-based application for making omics data actionable in clinical research and development. Discovery combines a powerful platform for...

June 11, 2012

NEW YORK--(BUSINESS WIRE)--Experts from Medidata Solutions (NASDAQ: MDSO) will be driving dialogue in nine conference sessions at the upcoming Drug Information Association’s (DIA) Annual Meeting.

June 11, 2012

SAN DIEGO--(BUSINESS WIRE)--Topera Announces Schedule for Cardiostim 2012; RhythmView™ and FIRMap™to be on display

June 11, 2012

EXTON, Pa.--(BUSINESS WIRE)--This trend represents a reversal from last year’s analysis when PPAR-gamma agonists captured a higher percentage of patient share across all lines of therapy.

June 11, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today that a poster entitled “LGD-6972, a Potent, Orally-Bioavailable, Small Molecule Glucagon Receptor Antagonist for the Treatment of Type 2 Diabetes” was...

June 11, 2012

HELSINKI--(BUSINESS WIRE)--FDA clears Nexstim's NexSpeech® navigated brain stimulation device for neurosurgical planning. Based on noninvasive TMS, NexSpeech may allow more patients with brain tumors to benefit from surgery.

June 11, 2012

LOS ANGELES--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (“KYTHERA”) today announced the presentation of initial trial results from Study ATX-101-10-17, the second of two pivotal European Phase III clinical trials with ATX-101, a facial...

June 11, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Knome announced the start of its early technology access program for knomeCLINIC, a software suite designed to help medical researchers and clinicians interpret human genomes for biological relevance.

June 11, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Knome, Inc., the human genome interpretation company, today announced that it has appointed Gary A. Cohen, JD, MPH, as Senior Vice President, General Counsel and Secretary of the company.

June 11, 2012

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), announced today that the Company plans to initiate two new LibiGel Phase III efficacy trials. This decision is based on an extensive analysis of previous efficacy...

June 11, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that Frank Reynolds, InVivo’s Chief Executive...

June 11, 2012

NORTH ANDOVER, Mass.--(BUSINESS WIRE)--MindChild Medical, Inc., today announced results of a recently sponsored national survey of hospital administrators and obstetricians (NSFM3) focused on trends in fetal monitoring. Recent fetal monitoring...

June 11, 2012

CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--Almac and VTU Technology announced today their collaboration to offer joint services for the expression of recombinant proteins with site-specific modification and labelling, such as PEGylation for...

June 10, 2012

ZURICH--(BUSINESS WIRE)--Meet the 25 companies and organizations in the SWISS Pavilion at BIO 2012 and get to know more about the highly successful Swiss Biotech industry.

June 9, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Attached is a press release issued earlier this morning by GlaxoSmithKline, announcing that detailed findings from the Harmony 6 Phase 3 study comparing albiglutide to prandial insulin (Lispro), were presented...

June 9, 2012

INGELHEIM, Germany & INDIANAPOLIS--(BUSINESS WIRE)--EX US & UK.Medical Media Only. Boehringer Ingelheim and Eli Lilly and Company (NYSE:LLY) today announced results from a post-hoc analysis that showed linagliptin is associated with...

June 9, 2012

INGELHEIM, Germany & INDIANAPOLIS--(BUSINESS WIRE)--Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) presented results from a randomised Phase III clinical trial and a post-hoc analysis for linagliptin at ADA. The results showed...

June 9, 2012

INGELHEIM, Germany & INDIANAPOLIS--(BUSINESS WIRE)--EX US & UK.Medical Media Only. Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) presented study results that showed the investigational SGLT-2 inhibitor empagliflozin*, alone...